Form 4: Myriad Genetics Chief Accounting Officer Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Natalie Munk, Chief Accounting Officer of Myriad Genetics, reports the disposal of 363 common stock shares to cover tax obligations related to vesting restricted stock units on March 25, 2024.
Summary
- On March 25, 2024, Natalie Munk, the Chief Accounting Officer of Myriad Genetics Inc., disposed of 363 shares of common stock.
- The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- The shares were disposed of at a price of $21.98 per share.
- Following the transaction, Munk directly owns 45,021 shares of Myriad Genetics Inc.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard tax-related transaction by a company officer. It doesn't indicate positive or negative sentiment regarding the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common occurrence when restricted stock units vest.
Key Dates
| Date | Description |
|---|---|
| 03/25/2024 | Date of transaction: disposal of shares to cover tax obligations. |
| 03/27/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.